ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

0R1B Biogen Inc

277.67
0.00 (0.00%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Biogen Inc 0R1B London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 277.67 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
277.67 277.67
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202415:05GLOBEBiogen Receives Positive CHMP Opinion for TOFIDENCE™..
06/3/202406:30UKREGNew Biomarker Data Add Further Evidence Supporting the..
04/3/202415:15UKREGBiogen Highlights New Data at the International Conference..
23/2/202406:00UKREGBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
12/2/202415:06UKREGBiogen Received European Commission Approval for SKYCLARYS®..
31/1/202406:30UKREGBiogen to Realign Resources for Alzheimer's Disease..
19/12/202306:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202308:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202305:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
06/11/202306:30GLOBEBiogen Appoints Monish Patolawala to its Board of Directors
25/10/202316:26GLOBEEisai Presents New LEQEMBI® (lecanemab-irmb) Investigational..
19/10/202306:30GLOBEBiogen to Present New Data at the Clinical Trials on..
26/9/202307:59GLOBEBiogen Completes Acquisition of Reata Pharmaceuticals
25/9/202300:02GLOBELEQEMBI® Intravenous Infusion (Lecanemab) Approved for the..
06/9/202306:30GLOBEBiogen Appoints Jane Grogan as Head of Research
06/8/202311:07ALNCNewsCORRECT: Biogens, Sage Therapeutics postpartum depression..
06/8/202308:17ALNCNewsBiogens, Sage Therapeutics postpartum depression treatment..
04/8/202321:41GLOBEFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
28/7/202306:05GLOBEBiogen to Acquire Reata Pharmaceuticals
19/7/202318:30GLOBEEisai Presents Latest Analysis of Lecanemab’s Effect on..
06/7/202319:00GLOBEFDA Grants Traditional Approval for LEQEMBI®..
12/6/202316:14GLOBEBiogen Announces Changes to Its Board of Directors
09/6/202317:45GLOBEFDA Advisory Committee Votes Unanimously to Confirm the..
09/6/202306:12ALNCNews*Nasdaq halts trading of Biogen stock
15/5/202318:30GLOBEHealth Canada Accepts New Drug Submission for Lecanemab as..

Su Consulta Reciente

Delayed Upgrade Clock